malaria_record: 121

Data license: Public Domain (CDC) · Data source: CDC Travelers' Health (Yellow Fever & Malaria, by country)

This data as json

record_id country_id valid_from valid_to is_current source_id fetch_run_id payload_sha256 content_hash area_of_risk_html relative_risk_html chloroquine_resist_html species_html recommended_prophylaxis_html cdc_updated_date has_transmission is_endemic whole_country_endemic country_has_any_prophylaxis_area screening_class prophylaxis_drugs_json species_json chloroquine_resistant area_summary created_at
121 121 2026-06-03   1 1 1 8eab5796788447f748d742bc3ea9c689b7dd02e0761828d2fa9fd151f54f3515 ca4975d0f39d46c9dceeb2eb43ffc8b05512e8446ae23d850b40db53909fdc07
  • Sudurpashchim and Karnali provinces in areas <2,000m (~6,500 ft) elevation
  • Rare cases in other areas throughout the country in areas <2,000 m (~6,500 ft) elevation
  • No malaria transmission in Kathmandu (the capital), Pokhara, or on typical Himalayan treks
  
  • Chloroquine
  • P. vivax (primarily)
  • P. falciparum (<10%)
  • Areas <2,000m in Sudurpashchim and Kernali Provinces: Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine2
  • All other areas with reported malaria transmission: No chemoprophylaxis recommended (insect bite precautions and mosquito avoidance only)4
Updated April 23, 2025
 2025-04-23 1 1 0 1 partial ["atovaquone-proguanil", "doxycycline", "mefloquine", "tafenoquine"] ["P. falciparum", "P. vivax"] 1 2 risk area statement(s); 1 no-transmission exclusion(s) 2026-06-03T22:10:28Z

Links from other tables